Refoxy Pharmaceuticals
The German startup is the first preclinical biotech company purposely developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases.
Refoxy Pharmaceuticals has raised €9.1M across 1 funding round from 4 investors, most recently a Seed round in Dec 2024. Based in Berlin, Germany; active in Healthtech. Data as of 28 Oct 2026.
Berlin, Germanywww.refoxy.com ↗
Total raised
€9.1M
€9,100,000
Funding rounds
1
Investors
4
distinct backers
Active since
2024-12
latest 2024-12
Funding by year
EUR raised per yearRefoxy Pharmaceuticals — funding by year — interactive chart.
Data table
| Refoxy Pharmaceuticals — funding by year | |
|---|---|
| 2024 | €9.1M |
Signals
High confidenceRaise-next likelihood33
base rate 44% for Seed
- ▼ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-04 | Seed | €9.1M | Apollo Health Ventures,Boehringer Ingelheim Venture Fund (BIVF),High-Tech Gründerfonds (HTGF),NRW.Venture | View deal → |
Investors
4Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData